Kyle Guse
2018
In 2018, Kyle Guse earned a total compensation of $905.3K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $329,006 |
| Salary | $408,000 |
| Other | $18,325 |
| Total | $905,331 |
Guse received $408K in salary, accounting for 45% of the total pay in 2018.
Guse also received $150K in non-equity incentive plan, $329K in option awards and $18.3K in other compensation.
Rankings
In 2018, Kyle Guse's compensation ranked 9,674th out of 14,244 executives tracked by ExecPay. In other words, Guse earned more than 32.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,674 out of 14,244 | 32nd |
Division Manufacturing | 3,893 out of 5,759 | 32nd |
Major group Chemicals And Allied Products | 1,465 out of 2,122 | 31st |
Industry group Drugs | 1,235 out of 1,811 | 32nd |
Industry Pharmaceutical Preparations | 950 out of 1,385 | 31st |
Source: SEC filing on April 12, 2019.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2018.
2018
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019